First elected: 2019
Year of birth: 1956
Carl-Johan Spak is Senior Vice President of Recipharm AB with responsibility for strategic investments and special projects. Carl-Johan has been employed in senior positions at Recipharm since 2009, with responsibility for – among other things – its overall development activities. Prior to that, Carl-Johan has been head of Meda’s Nordic organization and CEO of Recip AB. He is currently engaged as a board member of a number of different life science companies both in Sweden and internationally. Carl-Johan has a basic education as a dentist and a PhD in cariology and pharmacology at Karolinska Institutet in 1984.
Independence: Independent of the Company and the Executive Management and independent of major shareholders.
Other Board Assignments: SwedenBIO Service AB, Atrogi AB, XSpray Pharma AB (publ), Empros Pharma AB, Inject Pharma AB, Symcel AB, Recipharm Venture Fund AB, Follicum AB (publ), Buzzard Pharmaceuticals AB, KAHR Medical Ltd, Israel samt Binx Health Ltd, UK
Holdings: 7 539 shares.